Six presentations demonstrate Galapagos' commitment to the inflammatory bowel disease (IBD) communityNew analyses from Phase 3 SELECTION and SELECTION long-term extension (LTE) studies of Jyseleca® (filgotinib
Investegate announcements from Galapagos NV, Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023
German leaders see crisis as Catholics resign from the church therecordnewspaper.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from therecordnewspaper.org Daily Mail and Mail on Sunday newspapers.